Titanium Breast Marker Lawsuit (BioZorb)
The BioZorb titanium breast marker, implanted in breast cancer patients to guide radiation therapy, has been linked to chronic pain, device migration, and serious complications requiring surgical removal. If you received a BioZorb implant and suffered harm, you may be entitled to significant compensation.
Get A Free Case ReviewATTENTION: BIOZORB TITANIUM BREAST MARKER VICTIMS
If you or a loved one received a BioZorb titanium breast marker and suffered chronic pain, device migration, infection, or required surgical removal, you could be entitled to SIGNIFICANT compensation!
Consumers Injury Help offers a completely free case review. Hologic failed to adequately warn breast cancer patients about the risks associated with the BioZorb device. Time limits apply — find out if you qualify today.
Find Out if You Qualify
SIGNIFICANT Compensation May Be Available
LARGE SETTLEMENT AMOUNT
COULD BE CLAIMED
How do we help YOU?
Hologic marketed the BioZorb device to breast cancer patients as a dissolvable marker to guide radiation therapy — but the titanium clip framework does not dissolve, and thousands of patients were left with chronic pain, device migration, and the need for additional surgery. These patients deserve justice and full compensation.
How does filing a claim work?
- 1. Fill out our simple form. Or call to make your claim immediately.
- 2. Get a FREE case review from our expert partners.
- 3. We fight on your behalf for the highest compensation possible.
- 4. Claim your settlement!
- Remember: you only pay if you get a settlement! Our service is totally RISK FREE.
BioZorb caused preventable harm to breast cancer survivors — Hologic must be held accountable.
The BioZorb Tissue Marker was implanted in breast cancer patients following lumpectomy to mark the tumor bed for radiation targeting. Despite being marketed as absorbable, the permanent titanium clips remain in the body indefinitely. Thousands of patients reported chronic breast pain, device migration, infection, and visible protrusion — with many requiring painful surgical removal. Lawsuits allege Hologic knew of these risks and failed to adequately warn patients and surgeons.
What Is the BioZorb Titanium Breast Marker Lawsuit?
The BioZorb lawsuit involves legal claims filed by breast cancer patients who received the BioZorb Tissue Marker — a device implanted after lumpectomy to guide radiation therapy — and subsequently suffered chronic pain, device migration, infection, or required surgical removal. Manufactured by Hologic, the BioZorb device consists of a spiral scaffold with six titanium clips that were represented as dissolving over time, but the titanium framework remains permanently in the body.
Plaintiffs allege that Hologic knew about the high rate of complications and failure to absorb, yet continued to market the device without adequate warnings to patients or surgeons. Cases are being actively filed across the United States.
Who Can File a BioZorb Lawsuit?
You may be eligible to file a BioZorb lawsuit if you or a loved one received the BioZorb Tissue Marker following breast cancer surgery and subsequently experienced chronic breast pain, device migration, infection, visible protrusion of the device, or required surgery to remove it. Patients who were not fully informed of the device's permanent titanium components or its known complication rates may have strong claims.
Did your BioZorb implant cause pain, migration, or require removal?
Get A Free Case ReviewComplications Linked to the BioZorb Device
- Chronic breast pain — persistent pain at the implant site long after surgery
- Device migration — the titanium clips shifting from their original position
- Infection and abscess — requiring antibiotics or additional surgical treatment
- Tissue hardening (fibrosis) — scar tissue forming around the device
- Skin erosion — device protruding through or breaking down the overlying skin
- Nerve damage — numbness, tingling, or shooting pain in the breast or chest area
- Surgical removal — requiring an additional procedure to extract the titanium framework
BioZorb Lawsuit Status & Compensation
BioZorb lawsuits are being filed across the United States, with plaintiffs alleging product liability, negligence, and failure to warn against Hologic. Attorneys are actively accepting new clients. Cases assert that Hologic misrepresented the device as absorbable while knowing the titanium clip framework would remain permanently in the body.
Compensation may include medical expenses for treatment and surgical removal, lost wages during recovery, pain and suffering, emotional distress, and permanent scarring or disfigurement damages. There is no upfront cost — attorneys handle these cases on a contingency fee basis, meaning you only pay if you receive a settlement.